Skip to main content
. 2024 May 31;42(29):3400–3409. doi: 10.1200/JCO.24.00581

FIG 3.

FIG 3.

Time to intracranial progression by investigator assessment using modified RECIST, version 1.1, in (A) the intention-to-treat population, (B) patients with baseline brain metastases, and (C) patients without baseline brain metastases. HR, hazard ratio; IC, intracranial; NR, not reached.